Reimbursement realities: how payers evaluate CGTs

Securing reimbursement for CGTs requires understanding payer evaluation frameworks, outcome-based models, and budget impact considerations. This session explores how developers can navigate payer expectations to support patient access while maintaining commercial viability.

Key takeaways:

• Analyze payer assessment criteria for CGTs, including clinical evidence and long-term outcomes
• Explore innovative payment and risk-sharing models
• Assess strategies to demonstrate value and cost-effectiveness
• Discuss approaches to align therapy pricing with payer expectations